Skip to main content
. 2021 Dec 5;13(23):6124. doi: 10.3390/cancers13236124

Figure 8.

Figure 8

Differential capacity of edelfosine to induce apoptosis between pancreatic cancer cells and nontumorigenic cells. Human PANC-1 pancreatic cancer cells, nontumorigenic HPNE and normal fibroblasts show a different sensitivity to undergo apoptosis following treatment with edelfosine for the indicated incubation times and drug concentrations. The data are shown as the means ± SD of three independent experiments.